Can you take pioglitazone and Alogliptin?

Alogliptin and pioglitazone combination is used with proper diet and exercise to treat high blood sugar levels caused by type 2 diabetes. Alogliptin helps to control blood sugar levels by increasing substances in the body that make the pancreas release more insulin.

What is oseni used for?

Oseni (alogliptin and pioglitazone) is a combination antidiabetic medication used to treat and manage type 2 diabetes.

What is pioglitazone tablets used for?

Pioglitazone is a medicine used to treat type 2 diabetes. Type 2 diabetes is an illness where the body doesn’t make enough insulin, or the insulin that it makes doesn’t work properly. This can cause high blood sugar levels (hyperglycaemia).

What are the side effects of pioglitazone 15 mg?

More common

• Blurred vision or other changes in vision.
• flushed, dry skin.
• fruit-like breath odor.
• headache.
• increased thirst.
• increased urination.
• muscle pain or soreness.
• problems with your teeth.

How much alogliptin and pioglitazone should I take?

The tablets must not be split before swallowing. The recommended starting dose for OSENI (alogliptin and pioglitazone): for patients inadequately controlled on diet and exercise is 25 mg/15 mg or 25 mg/30 mg, for patients inadequately controlled on metformin monotherapy is 25 mg/15 mg or 25 mg/30 mg,

When to use Oseni in combination with pioglitazone?

OSENI is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both alogliptin and pioglitazone is appropriate [see Clinical Studies ].

How are Oseni tablets used to treat type 2 diabetes?

OSENI tablets contain two oral antihyperglycemic drugs used in the management of type 2 diabetes: alogliptin and pioglitazone. Alogliptin Alogliptin is a selective, orally bioavailable inhibitor of the enzymatic activity of dipeptidyl peptidase-4 (DPP-4).

What is the recommended dose of Oseni for metformin?

The recommended starting dose for OSENI (alogliptin and pioglitazone): for patients inadequately controlled on metformin monotherapy is 25 mg/15 mg or 25 mg/30 mg, for patients on alogliptin who require additional glycemic control is 25 mg/15 mg or 25 mg/30 mg,